Based on the results presented in this work, 50% of tested cell lines were velcrin-sensitive, but only 3% of glioblastoma neurospheres were predicted to be sensitive (including BT423, which has similar PDE3A expression levels to BT288L). Here, PDE3A is linked to glioblastoma.